Data such as single-family starts and supply-and-demand ratios portend to a much more stable housing recovery — not the bubble feared by many.

While some financial pundits fear the end of QE, many market watchers insist that the end of stimulus measures are bullish for stocks, not bearish.

Consumers might cheer lower prices, but this CPI data hints at a much darker issue: the specter of deflation and a downward spiral in spending.

Too-big-to-fail banks posed a huge problem during the mortgage meltdown, but a former CEO of Merrill Lynch warns that the problem of TBTF still looms large.

Asia and Europe might be grabbing negative headlines, but growth is slowing and stalling even in emerging markets, prompting investors to flee. You should too.

While the list of companies that spend the most lobbying money includes stocks you’d expect, like defense firm Northrop Grumman, others might surprise you.

Pandora’s shrewd buy of Rapid City’s KXMZ means it’ll pay less for content — a lot less. And that could be the difference between red and black on the balance sheet.

The flashy headline swings of the Dow and other major U.S. indices are sparking some investors to fret, but the worry over volatility is overblown.

A recent Nielsen study reports that 8 million Americans have bought a Herbalife product in the past 90 days. The stock’s still a bad buy, though.

Greece is the victim of an embarrassing “first,” as the country has been demoted by index-maker MSCI Inc. from developed to emerging status.